GNI Group
Manufacturing · Texas, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
PO Box 1914, Deer Park, Texas, 77536, Un...Phone Number
+81 362143600Website
www.gnipharma.comRevenue
$174.8 MillionStock Symbol
2160Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GNI Group
GNI Group is a global healthcare company headquartered in Japan, engaged in drug discovery, manufacturing, and sales through its consolidated subsidiaries. The company aims to deliver hope to patients worldwide by developing technologies and products that meet unmet medical needs. With a strong operational base in Japan, China, the United States, and Australia, GNI Group leverages its unique drug discovery platform to create high-quality and cost-effective solutions. The company is committed to sustainability and contributing to social issues and the achievement of SDGs through its business activities.Explore more
GNI Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GNI Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once GNI Group has new funding data
Earning: See what the market has to say on GNI Group recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at GNI Group
Check out if GNI Group is spiking on competitors!
Click to see if GNI Group had a recent Job posting/layoffs
GNI Group, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GNI Group launches new products
Check if GNI Group has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined GNI Group as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
GNI Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GNI Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GNI Group.
GNI Group Tech Stack
A closer look at the technologies used by GNI Group
Most Recent Scoops
Award
Award, Finance
Project
Spending/Investment
New Hire
Executive Move
New Hire
Executive Move
GNI Group News & Media
CATALYST BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Catalyst Biosciences, Inc. - CBIO
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the merger of Catalyst Biosciences, Inc. (NasdaqCM: CBIO) and GNI Group Ltd. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company’s shareholders. If you would like to discuss your legal rights regarding the proposed transaction, you may,GNI Group Ltd. Appoints of Kazuhiro Kawauchi as Chief Business Development Officer ...
GNI Group Ltd. announced appointment of Kazuhiro Kawauchi as Chief Business Development Officer, Effective from January 1, 2023. Career summary of Kazuhiro Kawauchi: Kyowa Hakko Kirin Co. Ltd. April... | December 29, 2022CBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Catalyst Biosciences, Inc. (NASDAQ: CBIO) and GNI Group Ltd. is fair to Catalyst shareholders. Halper Sadeh encourages Catalyst shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Catalyst and its board violatedCatalyst Biosciences Completes First Steps in Reverse Merger Plan
Acquires F351, a Phase 3 Drug to Treat Fibrosis
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GNI Group
Sign Up For FreeTo access detailed company insights
GNI Group is a global healthcare company headquartered in Japan, engaged in drug discovery, manufacturing, and sales through its consolidated subsidiaries. The company aims to deliver hope to patients worldwide by developing technologies and products that meet unmet medical needs. With a strong operational base in Japan, China, the United States, a... Read More
